Laidlaw Wealth Management LLC Danaher Corp Transaction History

Laidlaw Wealth Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$224.99 - $256.14 $288,437 - $328,371	-1,282 Reduced 20.6%	4,940 $1.19 Million
Q1 2023 May 12, 2023	BUY	$239.75 - $277.0 $231,119 - $267,028	964 Added 18.33%	6,222 $1.57 Million
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $289,945 - $339,030	-1,201 Reduced 18.59%	5,258 $1.4 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $4,694 - $28,640	19 Added 0.3%	6,459 $1.67 Million
Q2 2022 Aug 12, 2022	SELL	$237.11 - $299.66 $83,936 - $106,079	-354 Reduced 5.21%	6,440 $1.63 Million
Q1 2022 May 12, 2022	SELL	$257.27 - $315.76 $115,256 - $141,460	-448 Reduced 6.19%	6,794 $1.99 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $122,381 - $137,855	419 Added 6.14%	7,242 $2.38 Million
Q3 2021 Nov 12, 2021	BUY	$272.21 - $332.43 $1.86 Million - $2.27 Million	6,823 New	6,823 $2.08 Million
Q1 2021 May 17, 2021	SELL	$212.38 - $245.9 $1.25 Million - $1.45 Million	-5,889 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $1.25 Million - $1.45 Million	5,889 New	5,889 $1.31 Million

2,510

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $174B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Laidlaw Wealth Management LLC with notifications on news.